Skip to content

A Cohort Study on the Impact of Different Postoperative Treatment Strategies on Recurrence and Survival in Patients with Primary Liver Cancer

A Cohort Study on the Impact of Different Postoperative Treatment Strategies on Recurrence and Survival in Patients with Primary Liver Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109515
Enrollment
Unknown
Registered
2025-09-19
Start date
2025-09-22
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Liver Cancer

Interventions

Patients following surgery for primary hepatocellular carcinoma:None

Sponsors

The Third Affiliated Hospital of Naval Medical University(Eastern Hepatobiliary Surgery Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 70 years, of either sex, with a diagnosis of primary hepatocellular carcinoma.. 2. Patients who underwent curative hepatic resection. 3. Postoperative pathological confirmation of hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), or combined hepatocellular-cholangiocarcinoma. 4. Signed informed consent, with good compliance expected for long-term follow-up.

Exclusion criteria

Exclusion criteria: Patients with a history of other malignant tumors prior to surgery.

Design outcomes

Primary

MeasureTime frame
Tumor recurrence;Time to recurrence;Type of recurrence;Overall survival;Recurrence-free survival;Postoperative adjuvant therapy;Treatment compliance;

Secondary

MeasureTime frame
Tumor stage;Tumor size and number;Tumor differentiation grade;Microvascular invasion;Portal triad occlusion;Tumor markers;Immune indicators;Coagulation function;Liver function;Preoperative imaging examination;Postoperative imaging follow-up;

Countries

China

Contacts

Public ContactXia Yong

The Third Affiliated Hospital of Naval Medical University(Eastern Hepatobiliary Surgery Hospital)

xia.yong@126.com+86 136 0180 7601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026